Skip to content

Anesthesia in Flexible Bronchoscopy for Lung Cancer Diagnostic

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00440960
Enrollment
Unknown
Registered
2007-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2007-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

alfentanil, anesthesia, bronchoscopy, lidocaine, midazolam, propofol.

Brief summary

The objective of the study was to establish which anesthetic procedure used during flexible bronchoscopy has the lowest index of complications.

Detailed description

This prospective randomized study analyzed 80 patients that underwent flexible bronchoscopy. Patients were randomly assigned to four groups of 20 patients each according to the anesthetic combination used: 200 mg topical lidocaine (LID group); 200 mg topical lidocaine and 2 mg/kg propofol (PPF group); 200 mg topical lidocaine and 20 mcg/kg alfentanil (ALF group); or 200 mg topical lidocaine and 0.05 mg/kg midazolam (MID group). Scores were assigned to patients according to the different variables observed during the endoscopic procedure; the lower the score, the lower the complication index.

Interventions

DRUGpropofol
DRUGmidazolam
DRUGalfentanil
DRUGlidocaine

Sponsors

Hospital Pompeia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* The patients included in this study were referred to FBC for the investigation of bronchial carcinoma (diagnostic procedure). * Patients included in the study were classified as ASA I, II and II according to the anesthetic risk classification of the American Society of Anesthesiologists (ASA).

Exclusion criteria

* ASA IV classification of anesthesiology risk * procedure that lasted longer than 15 minutes * indication of therapeutic bronchoscopy * cardiac arrhythmia and / or hypoxemia detected at admission.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026